We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Stay up to date on the topics that matter to you

Prof. Dr. Hartmut Juhl profile page

Founder & CEO

at Indivumed Therapeutics

Prof. Dr. Hartmut Juhl is an entrepreneur, surgical oncologist and world-renowned researcher, dedicated to the science of tissue quality and its application to precision medicine in cancer diagnostics and therapeutics. He founded Indivumed in 2002 to decipher the complexity of cancer and to enable truly personalized medicine.

Got a Question for Prof. Dr. Hartmut Juhl?

Get in touch using the contact form linked here and we’ll get back to you shortly.

Published Content

Total: 1

Surgeons wearing blue gloves collecting tissue with forceps and placing into a tube.

Article

Tissue Is the Issue for Novel Cancer Drug Discovery

Standardized tissue handling is crucial in cancer research, ensuring the preservation of sample integrity and data quality. This enables comprehensive analysis and enhances understanding of cancer biology, aiding therapeutic discoveries.

Never miss a story

with the Breaking Science News daily newsletter